Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 807.70 Million |
| USD 1,451.27 Million | |
| % | |
|
Global Active Approximators Vascular Closure Device (VCDs) Market, By Type (Passive Approximators, Active Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology/ Vascular Surgery), Distribution Channel (Direct Tenders and Retail), Application (Diagnostic Intervention and Therapeutic Intervention), End User (Hospitals and Clinics, Specialty Centres, Ambulatory Surgery Centres and Others) – Industry Trends and Forecast to 2029
According to the WHO data, strokes and heart attacks account for more than four out of every five deaths caused by cardiovascular disorders, and one-third of these deaths are thought to happen before the age of 70. The European Society for Cardiology (ESC) (2021) reports that cardiovascular disease (CVD) kills 3.9 million people annually in Europe and more than 1.8 million people in the European Union. They account for roughly 45% of all deaths in Europe and 37% of deaths within the European Union.
Data Bridge Market Research analyses that the active approximators vascular closure device (VCDs) market which was USD 807.7 million in 2021, would rocket up to USD 1451.27 million by 2029, and is expected to undergo a CAGR of 7.60% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Passive Approximators, Active Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology/ Vascular Surgery), Distribution Channel (Direct Tenders and Retail), Application (Diagnostic Intervention and Therapeutic Intervention), End User (Hospitals and Clinics, Specialty Centres, Ambulatory Surgery Centres and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health (U.S.), Cardiva Medical, Inc. (U.S.), Medtronic (Ireland), Morris Innovative (U.S.), Teleflex Incorporated (U.S.), Merit Medical Systems (U.S.), Vasorum Ltd. (Ireland), TZ Medical, (U.S.), Vivasure Medical Ltd. (Ireland), Tricol Biomedical (U.S.), Scion Biomedical (U.S.), Advanced Vascular Dynamics (U.S.), Marine Polymer Technologies, Inc. (U.S.), Transluminal Technologies (U.S.)
|
|
Market Opportunities
|
|
Market Definition
After an angiography, a collagen or suture piece is utilised as a vascular closure device. Vascular closure devices are useful in angiogram leaves an artery puncture. The punctured arteries are sealed using vascular closure devices. The patients' bodies are not negatively affected by the vascular closure devices.
Drivers
In the entire world, cardiovascular diseases (CVDs) rank among the main causes of death. The American Heart Association (AHA) estimates that 18.6 million people died in 2019 as a result of CVDs, with the majority of these deaths occurring in Eastern Europe and Central Asia. According to the AHA's projections, 40.5 percent of the US population will have a CVD by 2030. Thus, the demand for catheterization and interventional treatments for diagnosing and treating CVDs is projected to rise as CVD prevalence rises. In the upcoming years, the market for active approximators vascular closure devices is projected to grow significantly due to the rising popularity of these treatments.
The main factors fuelling the growth of the active approximators vascular closure devices market is the rising prevalence of cardiovascular illnesses in the population. Other indirect factors influencing the growth of the market include increasing consumer disposable income and increasing players' focus on large-bore vascular closure devices. Growing vascular closure device approvals as well as consumer inclination for minimally invasive procedures will create more fruitful chances for market expansion. Increased obesity rates will also pave the ground for market expansion.
Opportunities
The growing patient population is a considerable need for surgical supplies (including medical equipment like vascular closure devices) at these recently opened surgical centres and hospitals. As the primary end users of vascular closure devices, the significant increase in hospitals and surgical facilities is anticipated to drive the growth of the active approximators vascular closure devices market.
Restraints/Challenges
When compared to manual compression devices, vascular closure devices are more expensive. Vascular closure devices typically cost between $150 and $250, whereas manual compression devices cost between $15 and $25. VCD expenses essentially add to the patient's hospital bill, raise hospitals' per-patient expenses, and at the same time lower their earnings. On the other hand, manual compression devices have very cheap prices when compared to vascular closure devices. As a result, one of the main factors restricting the market's growth is the high price of vascular closure devices. Another significant barrier limiting the market for these devices is the fact that hospitals are not compensated for vascular closure devices.
This active approximators vascular closure device (VCDs) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the active approximators vascular closure device (VCDs) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The COVID-19 outbreak's statewide lockdowns, refusal of wound care services, and cancellation or postponement of elective procedures, the market for active approximators vascular closure devices suffered in 2020. In order to reserve or reallocate the limited capacities and resources (such hospital beds and patient care specialists) toward COVID-19 patient care, elective procedures were being refused (cancelled/postponed). Additionally, many nations had implemented curfews and lockdowns to reduce the rising number of COVID-19 instances. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. The expansion of the market for active approximators vascular closure devices is anticipated to be constrained by this temporary denial of non-emergent healthcare services. However, it is anticipated that demand for active approximator vascular closure devices would increase in the upcoming years.
Recent Development
The active approximators vascular closure device (VCDs) market is segmented on the basis of type, access, procedure, distribution channel, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Distribution Channel
Application
End User
The active approximators vascular closure device (VCDs) market is analysed and market size insights and trends are provided by country, type, access, procedure, distribution channel, application, and end user as referenced above.
The countries covered in the active approximators vascular closure device (VCDs) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominated the global active approximators vascular closure devices market, due to the increasing prevalence of cardiovascular diseases.
Asia-Pacific is expected to witness the fastest growth in the next 7 years due to the emerging economies of China and India.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Global active approximators vascular closure device (VCDs) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global active approximators vascular closure device (VCDs) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Global active approximators vascular closure device (VCDs) market. The data is available for historic period 2010-2020.
The active approximators vascular closure device (VCDs) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to active approximators vascular closure device (VCDs) market.
Some of the major players operating in the active approximators vascular closure device (VCDs) market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.